Ieq Capital, LLC Astrazeneca PLC Transaction History
Ieq Capital, LLC
- $7.35 Billion
- Q2 2024
A detailed history of Ieq Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ieq Capital, LLC holds 37,265 shares of AZN stock, worth $2.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
37,265
Previous 28,206
32.12%
Holding current value
$2.8 Million
Previous $1.91 Million
52.15%
% of portfolio
0.04%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.88 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.2 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.05 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.76 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.32 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...